Clinical Study of Buthur Labaniyya (Acne vulgaris) and Therapeutic Evaluation of Unani Formulation of Dimad (Paste) in it’s management; An Open-label, block randomized, standard control study. - nil

Central Council for Research in Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1. Patients of age group 15-60 years.
•2. Clinically diagnosed patients of Buthur Labaniyya.
•3. Patients Irrespective of the gender.
•4. Patients with mild to moderate form of acne.
•5. Patients who will agree to sign the informed consent form & follow the protocol.

•1. Patients with severe form of acne.
•2. Diagnosed patients of PCOD.
•3. Patients having local wound and infection on face.
•4. Pregnant and lactating women.
•5. Patients with systemic diseases like DM, CKD, Chronic liver diseases,and history of Thyroid diseases or malignancies.
•6. Patients on corticosteroid therapy, anti-convulsant therapy or taking OCP.
•7. Patients suffering from other concomitant diseases like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc.

发起方

Central Council for Research in Unani Medicine New Delhi